• Data
    • Overview
    • Clinical notes
    • Images
    • Mother-child
    • Oncology
    • Regulatory grade
    • Truveta Language Model
    • Truveta Live Link
    • Truveta Studio
  • Genomics
  • Solutions
    • Medical devices
    • Life science
    • Public health
    • Healthcare
  • Research
  • Resources
  • About
    • Blog
    • Members
    • Leadership
    • Events & webinars
    • News
    • Careers
Get started
Sign in

Truveta in the news

For media inquiries, please email news@truveta.com

Some ER patients are half as likely to receive IV fluids since disruptions from Hurricane Helene

October 29, 2024

GLP-1 for Weight Loss: What Results You Can Expect Over Time

October 17, 2024

Surging demand leaves many without crucial diabetes and ADHD medications

October 10, 2024

How UnitedHealth turned a questionable artery-screening program into a gold mine

August 7, 2024

Zepbound outperforms Ozempic and Wegovy in head-to-head weight loss study

July 8, 2024

Mounjaro bests Ozempic for weight loss in first head-to-head comparison of real-world use

July 8, 2024

Ozempic v. Mounjaro? There’s a clear winner for weight loss, study finds

July 8, 2024

Mounjaro leads to significantly more weight loss than Ozempic, study suggests

July 8, 2024

CNN Exclusive: Adderall prescriptions have been filled less often amid ongoing shortage in the US

April 2, 2024
  • « Previous
  • 1
  • 2
  • 3

Ready to accelerate your research with representative, complete, and timely real-world data?

Truveta Data

Truveta Genome Project

Research

Resources

Blog

Newsroom

Careers

Privacy notice

Contact us

© Truveta 2026

Our website uses cookies to ensure you have the best experience.